Nataly Hasting

Founder and CEO
Cellestial Health

Dr Nataly Hastings is the founder and CEO of Cellestial Health, a pharmaceutical development company approaching brain disorders from a novel angle. This is based on her research at the University of Cambridge that identified networks of brain cells called astrocytes as therapeutic targets in Parkinson's, brain ageing, and beyond. Protecting these networks offers immunomodulatory benefits without the side effects of immunosuppression, tapping into the core of disease progression mechanisms.